Meaning-based Group Counselling for Bereavement

Phase 2

Completed

• Conditions: Grief; Bereavement
• Interventions: Behavioral: Conventional Bereavement Group; Behavioral: Meaning-Based Bereavement Group

• Registration Number: NCT01384942
• Lead Sponsor: Jewish General Hospital

Brief Summary

Given that individuals in bereavement tend to experience substantial psychological distress in the first two years following loss, individuals seeking psychological support will need appropriate services grounded in sound empirical scholarship. There is a lack of studies assessing bereavement groups, despite groups being one of the most common forms by which such services are offered. The prominent and emerging process of meaning-reconstruction in bereavement research is theorized to lead to better psychological adjustment and prevent more prolonged grief reactions. The principal objective of this study is to compare two types of group counseling for individuals in bereavement: A novel meaning-based bereavement counseling group and a conventional bereavement support group.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-06
• Study First Submitted: 2011-06-23
• Study First Submitted QC: 2011-06-28
• Study First Posted: 2011-06-29
• Primary Completion: 2012-03
• Status Verified: 2013-08
• Study Completion: 2013-10
• Last Update Submitted: 2013-11-07
• Last Update Posted: 2013-11-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 26

Inclusion Criteria

• Individuals presenting for bereavement services that have experienced a death-related loss within 6 weeks to 2 years of the first meeting of the group, and are experiencing an uncomplicated grief response will be invited to participate.
• Individuals will be assessed for their ability to participate in a group counselling context as well as an uncomplicated grief trajectory. Participants must be 18 years of age or older, have sufficient ability to communicate in English, as well as read English.

Exclusion Criteria

• Following a clinical/diagnostic interview and administration of the PG-13 (Prolonged Grief Disorder-13, Prigerson et al., 2009), individuals experiencing a complicated/prolonged grief trajectory are excluded.
• Furthermore, individuals whose cognitive condition might make the study burdensome or impossible for them are excluded.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Conventional Bereavement Group	Conventional Bereavement Group	-
Meaning-Based Bereavement Group	Meaning-Based Bereavement Group	-

Primary Outcome Measures

Name	Time	Method
Grief	24 weeks	Descriptive statistical analysis (e.g., means, standard deviations, percentage of scale range improvements) will be conducted on the pre-test, post-test, and follow-up scores for both the experimental and control group on the following outcome measures; (1) Grief: Revised Grief Experience Inventory; Core Bereavement; Hogan Grief Reaction Checklist
Meaning	24 weeks	Descriptive statistical analysis (e.g., means, standard deviations, percentage of scale range improvements) will be conducted on the pre-test, post-test, and follow-up scores for both the experimental and control group on the following outcome measures; (1) Meaning: Purpose in Life Test; The Grief and Meaning-Reconstruction Inventory; The Integration of Stressful Life Experiences Scale
Depression	24 Weeks	Descriptive statistical analysis (e.g., means, standard deviations, percentage of scale range improvements) will be conducted on the pre-test, post-test, and follow-up scores for both the experimental and control group on the following outcome measures; (1) Depression: Center for Epidemiologic Studies Depression Scale
Anxiety	24 Weeks	Descriptive statistical analysis (e.g., means, standard deviations, percentage of scale range improvements) will be conducted on the pre-test, post-test, and follow-up scores for both the experimental and control group on the following outcome measures; (1)Anxiety: State-Trait Anxiety Scale

Trial Locations

Locations (1)

S.M.B.D. Jewish General Hospital / Hope and Cope Program; 🇨🇦 Montreal, Quebec, Canada